Explore All Access
Check if your research matches the topics covered in BMC Cancer?
- Degree of match
- Common matching concepts
- Additional journal recommendations
BMC Cancer : Impact Factor & More
eISSN: 1471-2407pISSN: 1471-2407
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
BMC Cancer is a peer-reviewed open access medical journal that publishes original research on cancer and oncology. It was established in 2001 and is published by BioMed Central.
BMC Cancer Key Metrics
CiteScore 
6.7
Eigenfactor
0.05 - 0.1
Impact Factor
< 5
Scite Index
0.88 5-Year SI
SJR
Q2Genetics
SNIP
1.31
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months12%
4 to 6 months41%
7 to 9 months27%
Above 9 months20%
Did you find this useful?
Topics Covered on BMC Cancer
Cancer
Assay
Overall survival
Lung cancer
Gene expression
Lymph node
Chemotherapy
Positron emission tomography
Neuroendocrine tumors
Breast cancer
Confidence interval
Toxicity
Hepatocellular carcinoma
Radiation
Machine learning
Tumor microenvironment
Chemoradiotherapy
Lung
Cell growth
Cell cycle
BMC Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | GBP 2190 | USD 2990 | EUR 2590 |
| Publication Time | 19 |
| Editorial Review Process | Open peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in BMC Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in BMC Cancer
Mesenchymal stem cell-derived exosomes carrying miR-486-5p inhibit glycolysis and cell stemness in colorectal cancer by targeting NEK2.
- 6 Nov 2024
- BMC cancer
Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis.
- 6 Nov 2024
- BMC cancer
Assessing the impact of cervical cancer education in two high schools in Ghana.
- 6 Nov 2024
- BMC cancer
Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma.
- 6 Nov 2024
- BMC cancer
Predicting radiation pneumonitis in lung cancer using machine learning and multimodal features: a systematic review and meta-analysis of diagnostic accuracy.
- 5 Nov 2024
- BMC cancer
Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia
- 5 Nov 2024
- BMC Cancer
Mesenchymal stem cell-derived exosomes carrying miR-486-5p inhibit glycolysis and cell stemness in colorectal cancer by targeting NEK2.
- 6 Nov 2024
- BMC cancer
Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis.
- 6 Nov 2024
- BMC cancer
Assessing the impact of cervical cancer education in two high schools in Ghana.
- 6 Nov 2024
- BMC cancer
Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma.
- 6 Nov 2024
- BMC cancer
Predicting radiation pneumonitis in lung cancer using machine learning and multimodal features: a systematic review and meta-analysis of diagnostic accuracy.
- 5 Nov 2024
- BMC cancer
Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia
- 5 Nov 2024
- BMC Cancer
Compare Similar Journals with BMC Cancer
Select Journals to Compare with BMC Cancer
Total journals - 10
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Cancers
Publisher: MDPI
Annals of Oncology
Publisher: ELSEVIER
Oncotarget
Publisher: Impact Journals
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
Cancer Medicine
Publisher: WILEY
Medicine
Publisher: Elsevier
Scientific Reports
Publisher: NATURE PORTFOLIO
0 Journals Selected to compare with
BMC Cancer
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on BMC Cancer
How long has BMC Cancer been actively publishing? 
BMC Cancer has been in operation since 2001 till date.
What is the publishing frequency of BMC Cancer?
BMC Cancer published with a Continuous publication frequency.
How many articles did BMC Cancer publish last year?
In 2023, BMC Cancer publsihed 1262 articles.
What is the eISSN & pISSN for BMC Cancer?
For BMC Cancer, eISSN is 1471-2407 and pISSN is 1471-2407.
What is Citescore for BMC Cancer?
Citescore for BMC Cancer is 6.7.
What is SNIP score for BMC Cancer?
SNIP score for BMC Cancer is 1.31.
What is the SJR for BMC Cancer?
SJR for BMC Cancer is Q2.
Who is the publisher of BMC Cancer?
BMC is the publisher of BMC Cancer.
